Ticker Details
Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
IPO Date:	April 1, 1993
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$292.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.46%
Avg Daily Range (30 D):	$0.36 | 2.42%
Avg Daily Range (90 D):	$0.37 | 2.38%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.09M

Trade Size
Avg Trade Size (Sh.):	23
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	4,737
Avg Institutional Trade:	$1.26M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.66M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$1.18M
Avg Closing Volume:	6.75K

News

Mar 7, 2026 @ 6:15 AM Here's Why I Wouldn't Touch Amarin With a 10â€â... Source: Reuben Gregg Brewer

Nov 11, 2025 @ 7:27 PM RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE ... Source: Recordati S.P.A.

Nov 9, 2025 @ 9:15 PM New REDUCE-IT® Aspirin Analysis Presented at AH... Source: Amarin Corporation

Oct 14, 2025 @ 12:00 PM Amarin and HLS Therapeutics Collaborate on Present... Source: Amarin Corporation

Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.09	$	$-.09
Diluted EPS	$-.09	$	$-.09
Revenue	$213.65M	$49.22M	$213.65M
Gross Profit	$120.87M	$23.17M	$120.87M
Net Income / Loss	$-38.8M	$-1.22M	$-38.8M
Operating Income / Loss	$-50.17M	$-6.33M	$-50.17M
Cost of Revenue	$92.78M	$26.05M	$92.78M
Net Cash Flow	$13.52M	$11.76M	$13.52M
PE Ratio

Splits
Apr 11, 2025	1:20
Jan 18, 2008	1:10